Nivata IPO Market Data
Vishal Nirmiti
IPO GMP & Details
Check Vishal Nirmiti IPO GMP and its recorded history, price band, issue dates, total subscription, lot size and listing date. Unofficial GMP is not a listing forecast.
At a glance
Vishal Nirmiti IPO details
Unofficial market context
Vishal Nirmiti IPO GMP trend
The chart shows recent GMP movement over time. GMP is unofficial and should not be treated as a listing-price forecast or recommendation.
Latest chart observation+₹20
Change across recorded history−₹15
Recorded observations5
Current GMP reference price₹240
+₹35+₹20
1 Oct2 Oct
| Observation | GMP | Change | Reference price |
|---|---|---|---|
| 2 Oct 2026, 11:35 AM | +₹20 | ₹0 | ₹240 |
| 1 Oct 2026, 8:30 PM | +₹20 | −₹2 | ₹240 |
| 1 Oct 2026, 5:25 PM | +₹22 | −₹5 | ₹242 |
| 1 Oct 2026, 2:32 PM | +₹27 | −₹8 | ₹247 |
| 1 Oct 2026, 1:44 PM | +₹35 | — | ₹255 |
Issue schedule & market details
Vishal Nirmiti IPO key data
These are structured market-data fields. Missing values are left blank rather than estimated.
Issue typeMainboard
ExchangeBSE, NSE
Price band₹208 – ₹220
Issue price₹220
Issue size₹178 Cr
Open date30 Sep 2026
Close date5 Oct 2026
Listing date8 Oct 2026
Overall subscription0.57× subscribed
Last recorded GMP+₹20
GMP reference price₹240
Quick facts
Vishal Nirmiti IPO FAQs
When does the Vishal Nirmiti IPO open and close?
The opening date is 30 Sep 2026. The closing date is 5 Oct 2026.
When is the Vishal Nirmiti IPO listing date?
The currently recorded listing date is 8 Oct 2026. The timetable can change if the issue schedule is revised.
What is the Vishal Nirmiti IPO price band?
The currently recorded price band is ₹208 – ₹220.
What is the Vishal Nirmiti IPO GMP?
The latest GMP recorded by Nivata is +₹20. GMP is unofficial market information and is not a listing-price forecast.
What is the Vishal Nirmiti IPO subscription?
Nivata currently records overall issue subscription at 0.57 times. This is not an allotment probability.
This page contains factual IPO schedule, pricing, subscription, listing and GMP information. It does not contain an IPO research article and does not provide a recommendation, rating, target price, valuation conclusion, expected return, listing forecast, allotment probability or a view on whether to participate in the issue.